181 results
424B3
PRTG
Portage Biotech Inc
6 Mar 24
Prospectus supplement
9:36pm
of these development programs ; the Company’s clinical development of its product candidates, including the results of current and future clinical trials ; the benefits
6-K
EX-99.1
PRTG
Portage Biotech Inc
6 Mar 24
Current report (foreign)
9:11pm
product candidates, including the results of current and future clinical trials ; the benefits and risks of the Company's product candidates as compared
6-K
EX-99.1
PRTG
Portage Biotech Inc
28 Feb 24
Company focused on adenosine platform clinical development
6:42pm
and future clinical trials; the benefits and risks of the Company’s product candidates as compared to others; the Company’s maintenance and establishment
424B3
PRTG
Portage Biotech Inc
28 Feb 24
Prospectus supplement
5:19pm
portion of base salary, accrued unused vacation time and any unpaid expenses). Additionally, he may be entitled to Severance Benefits (as defined … , paid over 12 monthly installments. The CEO will be entitled to life insurance benefits and medical and dental benefits for a period of 12 months
6-K
EX-99.1
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
Benefits (as defined in the CEO Services Agreement), which include his then current base salary and the average of his annual bonus for the prior two … completed performance years, paid over 12 monthly installments. The CEO will be entitled to life insurance benefits and medical and dental benefits
6-K
EX-99.2
6lqmg7f15n
28 Feb 24
Current report (foreign)
5:17pm
424B3
7zh677urzr 1evxw3
18 Jan 24
Prospectus supplement
5:41pm
6-K
EX-99.1
ecmnx
18 Jan 24
Current report (foreign)
5:09pm
424B3
ae54 2989onhz7
4 Jan 24
Prospectus supplement
5:49pm
6-K
EX-99.1
dk30hz7
4 Jan 24
Current report (foreign)
8:10am
S-8
EX-4.2
z4q62
1 Dec 23
Registration of securities for employees
4:05pm
424B3
j0n8hj8
28 Nov 23
Prospectus supplement
4:03pm
6-K
EX-99.1
4x5li6len7c09ff
28 Nov 23
Current report (foreign)
4:01pm
6-K
EX-99.2
90qayjhciq5
28 Nov 23
Current report (foreign)
4:01pm
424B3
0swv ks1lf1vi492l0ta
14 Nov 23
Prospectus supplement
6:00am
6-K
EX-99.1
xrzwbq0zo9p1b6mv
13 Nov 23
Current report (foreign)
6:10am
424B3
giqdlxb7p97378l05
7 Nov 23
Prospectus supplement
4:50pm
F-1
3xi6sthii2f pjzah3b
31 Oct 23
Registration statement (foreign)
4:05pm
6-K
EX-4.2
i6a q6mhl
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-4.4
5w2i2jeinqcjtg
3 Oct 23
Current report (foreign)
4:05pm